Versemann, L.; Patil, S.; Steuber, B.; Zhang, Z.; Kopp, W.; Krawczyk, H.E.; Kaulfuß, S.; Wollnik, B.; Ströbel, P.; Neesse, A.;
et al. TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. Cancers 2022, 14, 3451.
https://doi.org/10.3390/cancers14143451
AMA Style
Versemann L, Patil S, Steuber B, Zhang Z, Kopp W, Krawczyk HE, Kaulfuß S, Wollnik B, Ströbel P, Neesse A,
et al. TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. Cancers. 2022; 14(14):3451.
https://doi.org/10.3390/cancers14143451
Chicago/Turabian Style
Versemann, Lennart, Shilpa Patil, Benjamin Steuber, Zhe Zhang, Waltraut Kopp, Hannah Elisa Krawczyk, Silke Kaulfuß, Bernd Wollnik, Philipp Ströbel, Albrecht Neesse,
and et al. 2022. "TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer" Cancers 14, no. 14: 3451.
https://doi.org/10.3390/cancers14143451
APA Style
Versemann, L., Patil, S., Steuber, B., Zhang, Z., Kopp, W., Krawczyk, H. E., Kaulfuß, S., Wollnik, B., Ströbel, P., Neesse, A., Singh, S. K., Ellenrieder, V., & Hessmann, E.
(2022). TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer. Cancers, 14(14), 3451.
https://doi.org/10.3390/cancers14143451